EP3019500
Nalmefensölt sem lyf til að draga úr áfengisneyslu eða til að koma í veg fyrir óhóflega áfengisneyslu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.7.2014EP published:
11.9.2019EP application number:
14738819.3
EP translation filed:
8.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
9.7.2034Expiry date:
9.7.2026Next due date:
31.7.2026
Title:
NALMEFENE SALTS AS MEDICAMENTS FOR REDUCING ALCOHOL CONSUMPTION OR FOR PREVENTING EXCESSIVE ALCOHOL CONSUMPTION
Timeline
Today
10.7.2014EP application
11.9.2019EP Publication
8.10.2019Translation submitted
15.11.2019Registration published
9.7.2026Expires
Owner
Name:
H. Lundbeck A/SAddress:
Ottiliavej 9, 2500, Valby, DK
Inventor
Name:
DE DIEGO, Heidi LopezAddress:
Nærum, DK
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201300421Date:
11.7.2013Country:
DK
Classification
Categories:
C07D 489/08, A61K 31/485, A61P 25/30
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.9.2020
Expires: 9.7.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.6.2021
Expires: 9.7.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.6.2022
Expires: 9.7.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.6.2023
Expires: 9.7.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.6.2024
Expires: 9.7.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.7.2025
Expires: 9.7.2026
Payer: Árnason Faktor ehf.